All posts

Explainers, essays and interactive guides, newest first. Every claim is referenced, and each post says when the evidence is thin.

46 posts

Tags: Music · Sleep · How research works · Meditation & mindfulness · For families · Creative code

No posts match. Try a different word, or choose All topics.

Keeping people safe

What prevents suicide, what lies underneath it, who carries the most risk, what the medicine warnings really mean, and a plan you can make in fifteen minutes.

  1. Keeping people safeWhat prevents suicide, how to check in on someone, the honest science on SSRIs, and what each of us can do.
  2. A plan for the hardest hourSafety planning: what the evidence says, how to make a plan, and a free tool to build yours, save it as a PDF or text it to someone you trust.
  3. What lies underneathHow science understands suicidal pain: the leading theories, from Joiner's interpersonal theory to the three-step model, and the neurobiology underneath.
  4. Not evenly sharedWho suicide touches most, by age, place, condition and community; why LGBTQ+ people carry higher risk; and what protects.
  5. The warning in the boxWhy some psychiatric medicines carry a suicide warning, which ones do and don't, what twenty years of science shows, and how to stay safe when treatment starts.
  6. Ketamine and the suicidal crisisWhat we know and what we don't, plus a white paper (PDF) that separates rapid relief of suicidal thinking from the unanswered question of prevention.

If you or someone you love is struggling right now, call or text 988 (US) or text HOME to 741741. Everything on this topic.

Research reports

Long, sourced reports on the compounds in clinical development: where each came from, how it works, what the trials show, and what is still unknown.

  1. Psilocybin and psilocin: a research reportTwo completed Phase 3 trials, an NDA in preparation, and an effect size worth arguing about.
  2. LSD: a research reportA circulatory stimulant that failed, became a counterculture, and is now in Phase 3 for generalized anxiety.
  3. MDMA: a research reportTwo positive Phase 3 trials, a 10 to 1 advisory vote against, and the rejection that reshaped a field.
  4. 5-MeO-DMT: a research reportThe largest reported effect size in the field, from the shortest session, and an indigenous tradition that appears to have been invented in 1984.
  5. 4-OH-DiPT: a research reportThe shortest-acting oral psychedelic Shulgin ever described, now a prodrug in three Phase 2 trials.
  6. Methylone: a research reportThirty years from a Shulgin patent to a Phase 3 PTSD candidate, by way of a smoke-shop shelf.

Everything on this topic.

Reference sites